The company announced that it received EXCiPACT certification in December 2015.
Roquette, a French excipient manufacturer, announced on March 23, 2016 that it has received EXCiPACT certification.
SGS, one of the international auditors authorized to grant approval under this standard, audited and recommended that Roquette’s facility in Lestrem, France, receive EXCiPACT certification. The company received its certification in December 2015. Roquette received certification for the following excipients:
“The EXCiPACT organization provides the suppliers’ customers (users) with high quality, reliable, and credible third-party certificates and audit reports,” said Paul Smaltz, head of Roquette’s pharma global business unit, in a statement. “This helps the suppliers’ customers to obtain the documentation required by their quality management systems, helping them meet their product regulatory requirements for excipients that have the same acceptance and value anywhere in the world.”
Source: Roquette
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.